- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
TRIGYN
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Trigyn Technologies Limited · Technology · Information Technology Services
Latest close
53.50 INR
-0.4%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -2.4% below the Trend Line and sits at 24.6% of its 52-week range. The latest completed week returned -0.4%, after a 2.0% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 51/100.
Setup score
35
out of 100
Latest Close
53.50 INR
7 Aug 2026
1W Return
-0.4%
latest completed week
4W Return
2.0%
short-term follow-through
12W Return
-5.1%
quarterly tape
Trend Breadth
9.6%
5 of 52 weeks active
Volume Ratio
2.2x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.4%
Latest completed week; four-week move 2.0%.
Indicator stack
5/47
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
12 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -2.4% below the Trend Line and sits at 24.6% of its 52-week range. The latest completed week returned -0.4%, after a 2.0% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.2x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1612-week average 0.20
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.16Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.0% over four weeks, -5.1% over 12 weeks, and -34.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year5
Trend breadth9.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.13Latest activity-pressure read.
Pressure change-64.8%Four-week change in activity pressure.
Leadership-14.66Latest relative-leadership reading.
RS change17.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength33/100Blend of value, momentum, and quality. Underlying universe rank 68; rank 1 is best.
Value44/100Relative valuation strength. Underlying universe rank 57; rank 1 is best.
Quality43/100Profitability and accounting quality. Underlying universe rank 58; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth43/100Revenue and earnings growth. Underlying universe rank 58; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 82.9x Price divided by trailing earnings.
- Price / sales
- 0.2x Market value relative to trailing revenue.
- EV / EBITDA
- 8.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -6.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 49.8% Gross profit retained from each unit of revenue.
- Operating margin
- 0.0% Operating profit retained from revenue.
- Free-cash-flow margin
- -1.1% Free cash flow generated from revenue.
- Return on invested capital
- 0.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 8.8% Latest one-year revenue growth.
- EPS growth
- -83.1% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -121.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -24.5x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 12 relevant articles.
1 positive · 11 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-47.8%Distance below the 52-week high.
13-week volatility4.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+16.2%Week of 10 Apr.
Worst week-11.8%Week of 27 Mar.
Latest week-0.4%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains5
Flat weeks0
Modest losses7
Sharp losses7
Recent vol4.4%13-week weekly-return volatility.
Base vol6.5%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew4.9% / -4.9%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Technology
4-week rank- / 100
Group average3.4%
Trend breadth58.0%
Trend58.0%active weekly trend signals
MD74.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryIN Information Technology Services
4-week rank35 / 67
Group average4.2%
Trend breadth34.3%
Trend34.3%active weekly trend signals
MD67.2%positive activity pressure
RS32.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape31/100
Trend, activity pressure, participation, and risk combine to a 31/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.
Activity pressure 0.16; No reversal markers Factors40/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 78; Buyback Yield rank 19 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 12 relevant articles.
Trigyn Technologies approves director appointments via postal ballot Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 53.50 INR | -0.4% | 54.82 INR | 95.57 INR | 0.13 | -14.66 | 261.1K | Off |
| 31 Jul 2026 | 53.72 INR | -1.4% | 55.14 INR | 96.03 INR | 0.19 | -14.40 | 116.6K | Off |
| 24 Jul 2026 | 54.50 INR | -1.9% | 55.59 INR | 96.50 INR | 0.29 | -11.66 | 127.6K | Off |
| 17 Jul 2026 | 55.53 INR | 5.9% | 55.99 INR | 96.97 INR | 0.36 | -12.73 | 408.1K | Off |
| 10 Jul 2026 | 52.43 INR | 0.1% | 56.38 INR | 97.47 INR | 0.36 | -17.77 | 94.1K | Off |
| 3 Jul 2026 | 52.40 INR | 0.4% | 56.95 INR | 97.98 INR | 0.41 | -18.69 | 51.3K | Off |
| 26 Jun 2026 | 52.17 INR | -8.5% | 57.61 INR | 98.33 INR | 0.48 | -19.02 | 0 | Off |
| 19 Jun 2026 | 57.00 INR | 4.8% | 58.24 INR | 98.66 INR | 0.60 | -12.07 | 9.0K | Off |
| 12 Jun 2026 | 54.39 INR | -3.6% | 58.70 INR | 98.97 INR | 0.60 | -15.23 | 22.4K | Off |
| 5 Jun 2026 | 56.44 INR | -2.6% | 59.42 INR | 99.30 INR | 0.59 | -11.80 | 32.0K | Off |
| 29 May 2026 | 57.95 INR | 0.9% | 59.98 INR | 99.64 INR | 0.68 | -10.72 | 147.9K | Off |
| 22 May 2026 | 57.46 INR | 1.9% | 60.59 INR | 99.97 INR | 0.69 | -12.77 | 105.3K | Off |
| 15 May 2026 | 56.39 INR | -10.5% | 61.28 INR | 100.3 INR | 0.65 | -14.64 | 156.7K | Off |
| 8 May 2026 | 63.03 INR | 6.3% | 61.95 INR | 100.7 INR | 0.67 | -7.23 | 166.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.